BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 19496069)

  • 21. MyD88-dependent nuclear factor-kappaB activation is involved in fibrinogen-induced hypertrophic response of cardiomyocytes.
    Li T; Wang Y; Liu C; Hu Y; Wu M; Li J; Guo L; Chen L; Chen Q; Ha T; Li C; Li Y
    J Hypertens; 2009 May; 27(5):1084-93. PubMed ID: 19342961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rho proteins are negative regulators of TLR2, TLR3, and TLR4 signaling in astrocytes.
    Borysiewicz E; Fil D; Konat GW
    J Neurosci Res; 2009 May; 87(7):1565-72. PubMed ID: 19115402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Regulation of immune suppressive cytokines by TLR4 activation in colon cancer cells].
    Qi HM; Zhu TM; Wang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jul; 12(4):413-5. PubMed ID: 19598032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells.
    Kundu SD; Lee C; Billips BK; Habermacher GM; Zhang Q; Liu V; Wong LY; Klumpp DJ; Thumbikat P
    Prostate; 2008 Feb; 68(2):223-9. PubMed ID: 18092352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TLR4 activation mediates kidney ischemia/reperfusion injury.
    Wu H; Chen G; Wyburn KR; Yin J; Bertolino P; Eris JM; Alexander SI; Sharland AF; Chadban SJ
    J Clin Invest; 2007 Oct; 117(10):2847-59. PubMed ID: 17853945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of CCAAT/enhancer-binding protein beta in proliferative inflammatory atrophy of the prostate: relation with the expression of COX-2, the androgen receptor, and presence of focal chronic inflammation.
    Wang W; Bergh A; Damber JE
    Prostate; 2007 Aug; 67(11):1238-46. PubMed ID: 17570496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TLR4 signaling in cancer cells promotes chemoattraction of immature dendritic cells via autocrine CCL20.
    Wang L; Liu Q; Sun Q; Zhang C; Chen T; Cao X
    Biochem Biophys Res Commun; 2008 Feb; 366(3):852-6. PubMed ID: 18083111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of PAR2 or/and TLR4 promotes SW620 cell proliferation and migration via phosphorylation of ERK1/2.
    Zhou B; Zhou H; Ling S; Guo D; Yan Y; Zhou F; Wu Y
    Oncol Rep; 2011 Feb; 25(2):503-11. PubMed ID: 21152870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primer: Toll-like receptor signaling pathways--what do rheumatologists need to know?
    O'Neill LA
    Nat Clin Pract Rheumatol; 2008 Jun; 4(6):319-27. PubMed ID: 18446139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of CC and CXC chemokines in human antigen-presenting dendritic cells by the pneumococcal proteins pneumolysin and CbpA, and the role played by toll-like receptor 4, NF-kappaB, and mitogen-activated protein kinases.
    Bernatoniene J; Zhang Q; Dogan S; Mitchell TJ; Paton JC; Finn A
    J Infect Dis; 2008 Dec; 198(12):1823-33. PubMed ID: 18945182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications.
    Wang JC; Bégin LR; Bérubé NG; Chevalier S; Aprikian AG; Gourdeau H; Chevrette M
    Clin Cancer Res; 2007 Apr; 13(8):2354-61. PubMed ID: 17406028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local overexpression of toll-like receptors at the vessel wall induces atherosclerotic lesion formation: synergism of TLR2 and TLR4.
    Shinohara M; Hirata K; Yamashita T; Takaya T; Sasaki N; Shiraki R; Ueyama T; Emoto N; Inoue N; Yokoyama M; Kawashima S
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2384-91. PubMed ID: 17872459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Toll-like receptors (TLRs) and TLR4 response to lipopolysaccharide in hen oviduct.
    Ozoe A; Isobe N; Yoshimura Y
    Vet Immunol Immunopathol; 2009 Feb; 127(3-4):259-68. PubMed ID: 19046776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of toll-like receptor 4 in colorectal cancer].
    Nihon-yanagi Y; Park Y; Ooshiro M; Terai K; Matsumoto T; Murano T; Okazumi S
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2247-9. PubMed ID: 19106585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TNF-alpha inhibits toll-like receptor 4 expression on monocytic cells via tristetraprolin during cardiopulmonary bypass.
    Tsai CS; Chen DL; Lin SJ; Tsai JC; Lin TC; Lin CY; Chen YH; Huang GS; Tsai HY; Lin FY; Li CY
    Shock; 2009 Jul; 32(1):40-8. PubMed ID: 19106809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expression.
    Hodgkinson CP; Ye S
    Pharmacogenet Genomics; 2008 Sep; 18(9):803-13. PubMed ID: 18698233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4.
    Voelcker V; Gebhardt C; Averbeck M; Saalbach A; Wolf V; Weih F; Sleeman J; Anderegg U; Simon J
    Exp Dermatol; 2008 Feb; 17(2):100-7. PubMed ID: 18031543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptor 4 signaling plays a role in triggering periodontal infection.
    Sun Y; Shu R; Zhang MZ; Wu AP
    FEMS Immunol Med Microbiol; 2008 Apr; 52(3):362-9. PubMed ID: 18328075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adiponectin increases motility of human prostate cancer cells via adipoR, p38, AMPK, and NF-kappaB pathways.
    Tang CH; Lu ME
    Prostate; 2009 Dec; 69(16):1781-9. PubMed ID: 19676095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TLR4-independent and PKR-dependent interleukin 1 receptor antagonist expression upon LPS stimulation.
    Na HY; Mazumdar K; Moon HJ; Chang S; Seong SY
    Cell Immunol; 2009; 259(1):33-40. PubMed ID: 19559408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.